loadpatents
name:-0.012834072113037
name:-0.0045859813690186
name:-0.0004570484161377
Zaror; Isabel Patent Filings

Zaror; Isabel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zaror; Isabel.The latest application filed is for "antagonist anti-cd40 monoclonal antibodies and methods for their use".

Company Profile
0.4.10
  • Zaror; Isabel - El Cerrito CA
  • Zaror; Isabel - Berkeley CA
  • Zaror, Isabel - Orinda CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use
App 20170081416 - Long; Li ;   et al.
2017-03-23
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use
App 20140205602 - Long; Li ;   et al.
2014-07-24
Antagonist anti-CD40 monoclonal antibodies and methods for their use
Grant 8,637,032 - Long , et al. January 28, 2
2014-01-28
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use
App 20130011405 - Long; Li ;   et al.
2013-01-10
Antagonist anti-CD40 antibodies
Grant 8,277,810 - Long , et al. October 2, 2
2012-10-02
Recombinant Interferon-beta With Enhanced Biological Activity
App 20090311216 - Johnson-Jackson; Deborah ;   et al.
2009-12-17
Antagonist Anti-cd40 Monoclonal Antibodies And Methods For Their Use
App 20080254026 - Long; Li ;   et al.
2008-10-16
Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use
App 20080057070 - Long; Li ;   et al.
2008-03-06
Use of Antagonist Anti-Cd40 Monoclonal Antibodies for Treatment of Multiple Myeloma
App 20070218060 - Long; Li ;   et al.
2007-09-20
Methods of therapy for b cell-related cancers
App 20070098718 - Long; Li ;   et al.
2007-05-03
Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
App 20070098717 - Long; Li ;   et al.
2007-05-03
Pichia secretory leader for protein expression
App 20030013154 - Crawford, Kenneth ;   et al.
2003-01-16
Chimeric MCP and DAF proteins with cell surface localizing domain
Grant 5,866,402 - Innis , et al. February 2, 1
1999-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed